SMOKELESS

World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 89: Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Lyon (France): World Health Organization, International Agency for Research on Cancer, 2007

U.S. Food and Drug Administration. FDA Parental Advisory on Flavored Tobacco Products – What You Need To Know. FDA. 7 March 2011. [accessed 2014 Oct http://www.fda.gov/TobaccoProducts/ProtectingKidsfromTobacco/FlavoredTobacco/ucm183196.html]

1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 89. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans.Lyon (FR): International Agency for Research on Cancer; 2007. 2. Hecht, S.S, and D. Hoffman. “Tobaccospecific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.” National Center for Biotechnology Information. U.S. National Library of Medicine, n.d. Web. 21 June 2016.

National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC). Smokeless Tobacco and Public Health: A Global Perspective. Bethesda, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute. NIH Publication No. 14-7983; 2014.

U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010